Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactofiltrum for Atopic Dermatitis in Adults
NCT01124318Phase 3Completed
- Sponsor
- AVVA RUS JSC
- Start
- May 2010
- Primary completion
- Sep 2010
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Lactofiltrum with Placebo (2 arms). Primary endpoint: SCORAD Index at Day 21. Started May 2010; status: completed.
02
Drugs
Lactofiltrum
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01124318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124318.